Modulation of TRP channel activity by hydroxylation and its therapeutic potential

Files

hdl_105843.pdf (648.16 KB)
  (Published version)

Date

2017

Authors

Nagarajan, Y.
Rychkov, G.
Peet, D.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Pharmaceuticals, 2017; 10(2):35-35

Statement of Responsibility

Yagnesh Nagarajan, Grigori Y. Rychkov and Daniel J. Peet

Conference Name

Abstract

Two transient receptor potential (TRP) channels-TRPA1 and TRPV3-are post-translationally hydroxylated, resulting in oxygen-dependent regulation of channel activity. The enzymes responsible are the HIF prolyl hydroxylases (PHDs) and the asparaginyl hydroxylase factor inhibiting HIF (FIH). The PHDs and FIH are well characterized for their hydroxylation of the hypoxic inducible transcription factors (HIFs), mediating their hypoxic regulation. Consequently, these hydroxylases are currently being targeted therapeutically to modulate HIF activity in anemia, inflammation, and ischemic disease. Modulating the HIFs by targeting these hydroxylases may result in both desirable and undesirable effects on TRP channel activity, depending on the physiological context. For the best outcomes, these hydroxylases could be therapeutically targeted in pathologies where activation of both the HIFs and the relevant TRP channels are predicted to independently achieve positive outcomes, such as wound healing and obesity.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

License

Call number

Persistent link to this record